Novolog Pharm Up 1966 NVLG.TA · ILA

Its shares trade on Tel Aviv under the ticker NVLG.TA. It has been listed since 28 February 2017. In the fiscal year to 31 December 2025, it reported revenue of ILS 1.81bn and net income of ILS 4.1m. At that date it held total assets of ILS 2.15bn and shareholders' equity of ILS 356.9m.

Novolog (Pharm UP 1966) Ltd. engages in the provision of healthcare services. The firm is a logistical partner for domestic and multinational pharmaceutical and medical device companies operating in Israel. The company mainly serves pharmacies, hospitals, and patients at home. The firm operates through its subsidiaries, which include: Care for Life-Professional Nurses Service, which provides a range of in-home services for patients by trained nurses and trained assistants, as well as Trialog-Clinical Trial Logistics, which specializes in logistics for clinical trials and works with pharmaceutical and Clinical Research Organization (CRO) companies that perform clinical trials in Israel.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Rami DarChairman of the Board, since 2017
• Mr. Eran TausChief Executive Officer
• Mr. Ofer AmarChief Executive Officer of a Subsidiary
• Mr. Rafi FriedmanChief Executive Officer of a Subsidiary
• Mr. Boaz GershonChief Executive Officer of a Subsidiary
• Mr. Ran LaorExecutive Vice President - Finance, since 2011
• Ms. Sivan RazVice President of Human Resources
• Mr. Ofir Shani SharabaniVice President-Information Systems
• Mr. Assaf VardiVice President - Business Development, Sales & Marketing
• Mr. Joseph GinossarInternal Audit
• Mr. Doron SteigerDirector
• Mr. Nitay TalDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.